The global Prostate Specific Antigen (PSA) Testing market was valued at USD 5.56 billion in 2026 and is projected to reach USD 10.05 billion by 2034, expanding at a CAGR of 6.9% during the forecast period. Market growth is driven by the increasing prevalence of prostate cancer, growing awareness of early diagnosis, expanding preventive healthcare programs, and continued advancements in...
0 Commentarios
0 Veces compartido
63 Visualizaciones
0 Reseñas
Patrocinados
Patrocinados
Patrocinados
Telodosocial – Condividi ricordi, connettiti e crea nuove amicizie,eldosocial – Share memories, connect and make new friendshttps://telodosocial.it